Physician profile
Charles E Turk
NPI 1073616637
$916.72
in general payments reported to CMS, 2019-2025
11 companies · $43.18 in 2025
The $43.18 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.21 · 2020: $18.51 · 2021: $198 · 2022: $260 · 2023: $326 · 2024: $52.83 · 2025: $43.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $197.53 | 2021 | |
| Dendreon Pharmaceuticals LLC | $156.63 | 2023-2024 | Provenge |
| Teleflex LLC | $147.01 | 2022 | |
| Palette Life Sciences, INC. | $118.59 | 2023 | |
| Myriad Genetic Laboratories, INC. | $89.21 | 2022-2023 | Prolaris |
| Antares Pharma, INC. | $51.32 | 2022 | |
| Progenics Pharmaceuticals, INC. | $43.18 | 2025 | |
| Coloplast Corp | $40.45 | 2022-2023 | Coloplast Tfl Drive |
| Endo Pharmaceuticals INC. | $37.72 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $19.31 | 2024 | |
| Lantheus Medical Imaging, INC. | $15.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Turk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.